International CBD brand Elixinol has appointed a former supplement-industry executive as its new global CEO – the Australian company’s second management reshuffle in less than a month.
Oliver Horn formerly served as head of Swisse Wellness for Australia, New Zealand and North America. He takes over from Stratos Karousos as Elixinol Global CEO with immediate effect, according to the company’s leadership page.
The shakeup comes just months after Elixinol divested from its Australian hemp food subsidiary and medical marijuana ventures to pivot toward CBD supplements. Karousos was appointed Elixinol CEO in June of last year, and the company appointed a new CEO for North and South America last month.
“Since Oliver joined the board earlier this month, it became apparent that he could create immense value in a leadership position,” Elixinol chairman and founder Paul Benhaim said, according to a Tuesday report by Business News Australia.
Horne previously served in leadership positions at Treasury Wine Estates and worked in corporate finance, the report said.
Elixinol Global trades on the Australian Stock Exchange under the ticker symbol EXL.
